WNT2 and esophageal squamous cell carcinoma: They demonstrated that WNT2+ inhibits the activation of the JAK2/STAT3 signaling cascade by affecting the secretion of SOCS3, thereby suppressing T-cell differentiation and expression and promoting immune evasion in ESCC.